相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The combination of Biochanin A and SB590885 potentiates the inhibition of tumour progression in hepatocellular carcinoma
Yi Xiao et al.
CANCER CELL INTERNATIONAL (2020)
Biochanin A: A novel bioactive multifunctional compound from nature
Ayesha Sarfraz et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2020)
The role of mitophagy in innate immune responses triggered by mitochondrial stress
Yinjuan Song et al.
CELL COMMUNICATION AND SIGNALING (2020)
Dietary isoflavones or isoflavone-rich food intake and breast cancer risk: A meta-analysis of prospective cohort studies
Ting-Ting Zhao et al.
CLINICAL NUTRITION (2019)
Breast Cancer Treatment A Review
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Current Landscape of Immunotherapy in Breast Cancer: A Review
Sylvia Adams et al.
JAMA ONCOLOGY (2019)
Methylglyoxal in combination with 5-Fluorouracil elicits improved chemosensitivity in breast cancer through apoptosis and cell cycle inhibition
Sonali Ghosh et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Functional daidzein enhances the anticancer effect of topotecan and reverses BCRP-mediated drug resistance in breast cancer
Jianli Guo et al.
PHARMACOLOGICAL RESEARCH (2019)
Combination of Biochanin A and Temozolomide Impairs Tumor Growth by Modulating Cell Metabolism in Glioblastoma Multiforme
Vilas Desai et al.
ANTICANCER RESEARCH (2019)
Immunotherapy, an evolving approach for the management of triple negative breast cancer: Converting non-responders to responders
Mai F. Tolba et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Anti-proliferative activity of biochanin A in human osteosarcoma cells via mitochondrial-involved apoptosis
Yen-Nien Hsu et al.
FOOD AND CHEMICAL TOXICOLOGY (2018)
Biochanin A: A phytoestrogen with therapeutic potential
Shikha Raheja et al.
TRENDS IN FOOD SCIENCE & TECHNOLOGY (2018)
Antiproliferative Activity of Combined Biochanin A and Ginsenoside Rh2 on MDA-MB-231 and MCF-7 Human Breast Cancer Cells
Guixing Ren et al.
MOLECULES (2018)
Formulation and Optimization of Doxorubicin and Biochanin A Combinational Liposomes for Reversal of Chemoresistance
Tapan K. Dash et al.
AAPS PHARMSCITECH (2017)
Biochanin-A induces apoptosis and suppresses migration in FaDu human pharynx squamous carcinoma cells
In-A Cho et al.
ONCOLOGY REPORTS (2017)
Apigenin potentiates the antitumor activity of 5-FU on solid Ehrlich carcinoma: Crosstalk between apoptotic and JNK-mediated autophagic cell death platforms
Hanaa H. Gaballah et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2017)
Estrogen receptor agonists/antagonists in breast cancer therapy: A critical review
A. Jameera Begam et al.
BIOORGANIC CHEMISTRY (2017)
Novel combination of sorafenib and biochanin-A synergistically enhances the anti-proliferative and pro-apoptotic effects on hepatocellular carcinoma cells
Mohieldin M. Youssef et al.
SCIENTIFIC REPORTS (2016)
Biochanin A Promotes Proliferation that Involves a Feedback Loop of MicroRNA-375 and Estrogen Receptor Alpha in Breast Cancer Cells
Jian Chen et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Estrogen receptors in breast carcinogenesis and endocrine therapy
Bo Huang et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
QUANTITY: An Isobaric Tag for Quantitative Glycomics
Shuang Yang et al.
SCIENTIFIC REPORTS (2015)
Pterostilbine, an active component of blueberries, sensitizes colon cancer cells to 5-fluorouracil cytotoxicity
Mai F. Tolba et al.
SCIENTIFIC REPORTS (2015)
Biochanin A Gastroprotective Effects in Ethanol-Induced Gastric Mucosal Ulceration in Rats
Maryam Hajrezaie et al.
PLOS ONE (2015)
Biochanin A reduces pancreatic cancer survival and progression
Vikas Bhardwaj et al.
ANTI-CANCER DRUGS (2014)
Targeting the PI3K/AKT/mTOR pathway in estrogen receptor-positive breast cancer
Eva Maria Ciruelos Gil
CANCER TREATMENT REVIEWS (2014)
Biochanin-A ameliorates behavioural and neurochemical derangements in cognitive-deficit mice for the betterment of Alzheimer's disease
S. M. Biradar et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2014)
Drug combinations with quercetin: doxorubicin plus quercetin in human breast cancer cells
Davide Staedler et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer
Todd W. Miller et al.
BREAST CANCER RESEARCH (2011)
Effect of Combination Treatment of Rapamycin and Isoflavones on mTOR Pathway in Human Glioblastoma (U87) Cells
Shilpa Puli et al.
NEUROCHEMICAL RESEARCH (2010)
Biochanin A Modulates Cell Viability, Invasion, and Growth Promoting Signaling Pathways in HER-2-Positive Breast Cancer Cells
Vikas Sehdev et al.
JOURNAL OF ONCOLOGY (2009)
Antioxidant potential by arabinoxylan rice bran, MGN-3/biobran, represents a mechanism for its oncostatic effect against murine solid Ehrlich carcinoma
Eman Noaman et al.
CANCER LETTERS (2008)
Ligand-dependent interaction between estrogen receptor α and adenomatous polyposis coli
Alexander P. Kouzmenko et al.
GENES TO CELLS (2008)
Biochanin A Inhibits Breast Cancer Tumor Growth in A Murine Xenograft Model
Young Jin Moon et al.
PHARMACEUTICAL RESEARCH (2008)
Survivin and caspase-3 expression in breast cancer: Correlation with prognostic parameters, proliferation, angiogenesis, and outcome
Aziza Nassar et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2008)
Evaluation of the effect of Paclitaxel, Epirubicin and Tamoxifen by cell kinetics parameters in estrogen-receptor-positive Ehrlich Ascites Tumor (EAT) cells growing in vitro
G. Ozcan Arican et al.
ACTA BIOLOGICA HUNGARICA (2007)
Mechanisms of Disease: angiogenesis and the management of breast cancer
Susana Banerjee et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2007)
Phytoestrogens and breast cancer - promoters or protectors?
Suman Rice et al.
ENDOCRINE-RELATED CANCER (2006)
A pharmacokinetic-based test to prevent severe 5-fluorouracil toxicity
Guido Bocci et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Angiogenesis in cancer
Naoyo Nishida et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2006)
Activation of vascular endothelial growth factor (VEGF) by the ER-alpha variant, ER Delta 3
S Koduri et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Mammalian lignans and genistein decrease the activities of aromatase and 17β-hydroxy steroid dehydrogenase in MCF-7 cells
JD Brooks et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)
5-Fluorouracil: Mechanisms of action and clinical strategies
DB Longley et al.
NATURE REVIEWS CANCER (2003)
Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance
E Devarajan et al.
ONCOGENE (2002)
Estrogen receptor breast cancer phenotypes in the surveillance, epidemiology, and end results database
WF Anderson et al.
BREAST CANCER RESEARCH AND TREATMENT (2002)
Assaying the estrogenicity of phytoestrogens in cells of different estrogen sensitive tissues
E Schmitt et al.
TOXICOLOGY IN VITRO (2001)
Different effects of genistein on molecular markers related to apoptosis in two phenotypically dissimilar breast cancer cell lines
J Xu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2001)